{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:30:57Z","timestamp":1765279857343},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1245\/s10434-014-4330-1","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T10:57:43Z","timestamp":1420714663000},"page":"2573-2577","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"22","author":[{"given":"S.","family":"Bhagwandin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Naffouje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Salti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"issue":"10","key":"4330_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1245\/ASO.2005.12.001","volume":"12","author":"JH Stewart IV","year":"2005","unstructured":"Stewart IV JH, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 2005;12(10):765\u201377.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"4330_CR2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jso.23189","volume":"107","author":"TC Chua","year":"2013","unstructured":"Chua TC, Esquivel J, Pelz JO, Morris DL. Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol. 2013;107(6):566\u201373.","journal-title":"J Surg Oncol."},{"issue":"3","key":"4330_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clcc.2012.01.001","volume":"11","author":"T Weber","year":"2012","unstructured":"Weber T, Roitman M, Link KH. Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Clin Colorectal Cancer. 2012;11(3):167\u201376.","journal-title":"Clin Colorectal Cancer."},{"issue":"8","key":"4330_CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.2042-7158.1994.tb03883.x","volume":"46","author":"T Kuzuya","year":"1994","unstructured":"Kuzuya T, Yamauchi M, Ito A, Hasegawa M, Hasegawa T, Nabeshima T. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy. J Pharm Pharmacol. 1994;46(8):685\u20139.","journal-title":"J Pharm Pharmacol."},{"issue":"5","key":"4330_CR5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1245\/s10434-012-2240-7","volume":"19","author":"GI Salti","year":"2012","unstructured":"Salti GI, Ailabouni,L, Undevia S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis. Ann Surg Oncol. 2012;19(5):1410\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"4330_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4251\/wjgo.v3.i12.169","volume":"3","author":"A Macr\u00ec","year":"2011","unstructured":"Macr\u00ec A, Fortugno A, Saladino E. Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. World J Gastrointest Oncol. 2011;3(12):169.","journal-title":"World J Gastrointest Oncol."},{"issue":"3","key":"4330_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","volume":"14","author":"PH Sugarbaker","year":"1998","unstructured":"Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998;14 (3):254\u201361.","journal-title":"Semin Surg Oncol."},{"key":"4330_CR8","doi-asserted-by":"crossref","unstructured":"Jacquet P, Sugarbaker PH. Peritoneal carcinomatosis: principles of management. In: Sugarbaker PH, editor. Boston: Kluwer Academic Publishers; 1996. p. 359.","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"10","key":"4330_CR9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ejso.2006.05.011","volume":"32","author":"K Schmid","year":"2006","unstructured":"Schmid K, Boettcher MI, Pelz JOW, Meyer T, Korinth G, Angerer J, Drexler H. Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with mitomycin C.\u00a0Eur J Sur Oncol.\u00a02006;32(10):1222\u20135.","journal-title":"Eur J Sur Oncol."},{"issue":"8","key":"4330_CR10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0959-8049(01)00058-2","volume":"37","author":"AJ Witkamp","year":"2001","unstructured":"Witkamp AJ, De Bree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer.\u00a02001;37(8):979\u201384.","journal-title":"Eur J Cancer."},{"issue":"4","key":"4330_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jso.21051","volume":"98","author":"S Kusamura","year":"2008","unstructured":"Kusamura S, Dominique E, Baratti D, Younan R, Deraco M. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2008;98(4):247\u201352.","journal-title":"J Surg Oncol."},{"issue":"17","key":"4330_CR12","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.2004.05.065","volume":"22","author":"D Schrag","year":"2004","unstructured":"Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD, Somerfield MR. American Society of Clinical Oncology Technology assessment: chemotherapy sensitivity and resistance assays.\u00a0J Clin Oncol. 2004;22(17):3631\u20138.","journal-title":"J Clin Oncol."},{"issue":"17","key":"4330_CR13","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2004.04.077","volume":"22","author":"DJ Samson","year":"2004","unstructured":"Samson DJ, Seidenfeld J, Ziegler K, Aronson N. Chemotherapy sensitivity and resistance assays: a systematic review.\u00a0J Clin Oncol.\u00a02004;22(17):3618\u201330.","journal-title":"J Clin Oncol."},{"issue":"4","key":"4330_CR14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1048-891X.2004.14408.x","volume":"14","author":"P Kornblith","year":"2004","unstructured":"Kornblith P, Ochs RL, Wells A, Gabrin MJ, Piwowar J, Chattopadhyay A, Burholt D. Differential in vitro effects of chemotherapeutic agents on primary cultures of human ovarian carcinoma. Int J Gynecol Cancer,\u00a02004;14(4):607\u201315.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"4330_CR15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","volume":"21","author":"K Turaga","year":"2014","unstructured":"Turaga K, Levine E, Barone R, SticcaR, Petrelli N, Lambert L, Esquivel J. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.\u00a0Ann Surg Oncol.\u00a02014;21(5):1501\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"4330_CR16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1525-1438.2006.00301.x","volume":"16","author":"H Gallion","year":"2006","unstructured":"Gallion H, Christopherson WA, Coleman RL, DeMars L, Herzog T, Hosford S, Sevin BU. Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay.\u00a0Int J Gynecol Cancer.\u00a02006;16(1):194\u2013201.","journal-title":"Int J Gynecol Cancer."},{"issue":"1","key":"4330_CR17","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2010.01.059","volume":"203","author":"TJ Herzog","year":"2010","unstructured":"Herzog TJ, Krivak TC, Fader AN, Coleman RL. Chemosensitivity testing with ChemoFx and overall survival in primary ovarian cancer. Am J Obstet Gynecol. 2010;203(1):68.e1\u20136.","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"4330_CR18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2013.08.009","volume":"131","author":"T Rutherford","year":"2013","unstructured":"Rutherford T, Orr Jr J, Grendys Jr E, Edwards R, Krivak TC, Holloway R, Herzog TJ. A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer.\u00a0Gynecol Oncol.\u00a02013;131(2):362\u20137.","journal-title":"Gynecol Oncol."},{"key":"4330_CR19","unstructured":"NCCN Guidelines Version 3. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf . 2014;14."},{"issue":"1","key":"4330_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.6004\/jnccn.2011.0010","volume":"9","author":"M Markman","year":"2011","unstructured":"Markman M. Counterpoint: chemosensitivity assays for recurrent ovarian cancer.\u00a0J Natl Compr Cancer Netw.\u00a02011;9(1):121\u20134.","journal-title":"J Natl Compr Cancer Netw."},{"issue":"2","key":"4330_CR21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clcc.2011.03.006","volume":"10","author":"P Cashin","year":"2011","unstructured":"Cashin P, Nygren P, Hellman P, Granberg D, Andr\u00e9asson H, Mahteme H. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer.\u00a02011;10(2):108\u201312.","journal-title":"Clin Colorectal Cancer."},{"issue":"2","key":"4330_CR22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","volume":"243","author":"MJ Koppe","year":"2006","unstructured":"Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243(2):212.","journal-title":"Ann Surg."},{"issue":"2","key":"4330_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221(2):124\u201332.","journal-title":"Ann Surg."},{"issue":"8","key":"4330_CR24","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","volume":"13","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol. 2012:13(8):e362\u20139.","journal-title":"Lancet Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4330-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4330-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T08:18:17Z","timestamp":1566202697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4330-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["4330"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4330-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]}}}